Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

De novo membranous nephropathy in renal allograft associated with antibody-mediated rejection and review of the literature.

Patel K, Hirsch J, Beck L, Herlitz L, Radhakrishnan J.

Transplant Proc. 2013 Nov;45(9):3424-8. doi: 10.1016/j.transproceed.2013.05.011. Review.

PMID:
24182829
2.

De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?

Ponticelli C, Glassock RJ.

Transpl Int. 2012 Dec;25(12):1205-10. doi: 10.1111/j.1432-2277.2012.01548.x. Epub 2012 Aug 21. Review.

3.

C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury.

Lim BJ, Kim MS, Kim YS, Kim SI, Jeong HJ.

Transplant Proc. 2012 Apr;44(3):619-20. doi: 10.1016/j.transproceed.2011.12.052.

PMID:
22483452
4.

De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney.

Honda K, Horita S, Toki D, Taneda S, Nitta K, Hattori M, Tanabe K, Teraoka S, Oda H, Yamaguchi Y.

Clin Transplant. 2011 Mar-Apr;25(2):191-200. doi: 10.1111/j.1399-0012.2010.01213.x.

PMID:
20236137
5.

Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.

Choi J, Cho YM, Yang WS, Park TJ, Chang JW, Park SK.

Clin Transplant. 2007 Mar-Apr;21(2):159-65. Review.

PMID:
17425739
6.

Recurrence of de novo membranous glomerulonephritis on renal grafts.

Heidet L, Gagnadoux ME, Beziau A, Niaudet P, Broyer M, Habib R.

Clin Nephrol. 1994 May;41(5):314-8.

PMID:
8050213
8.

Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss.

Everly MJ, Everly JJ, Arend LJ, Brailey P, Susskind B, Govil A, Rike A, Roy-Chaudhury P, Mogilishetty G, Alloway RR, Tevar A, Woodle ES.

Am J Transplant. 2009 May;9(5):1063-71. doi: 10.1111/j.1600-6143.2009.02577.x. Epub 2009 Mar 16.

9.

Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation.

Schwarz A, Krause PH, Offermann G, Keller F.

Transplantation. 1994 Sep 27;58(6):650-4.

PMID:
7940683
10.

De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature.

Truong L, Gelfand J, D'Agati V, Tomaszewski J, Appel G, Hardy M, Pirani CL.

Am J Kidney Dis. 1989 Aug;14(2):131-44. Review.

PMID:
2667346
11.

Posttransplant de novo membranous nephropathy in childhood.

Sebire NJ, Bockenhauer D.

Fetal Pediatr Pathol. 2005 Mar-Apr;24(2):95-103.

PMID:
16243754
12.

Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.

Regele H, Böhmig GA, Habicht A, Gollowitzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M.

J Am Soc Nephrol. 2002 Sep;13(9):2371-80.

13.

Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).

Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V.

Transplantation. 1999 Sep 15;68(5):635-41.

PMID:
10507481
14.

Late acute antibody mediated rejection after nine years of renal transplantation.

Halim MA, Al-Otaibi T, Al-Waheeb S, Tawab KA, El Kholy O, Nair P, Said T, Narayanan Nampoory MR.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1111-4.

15.

Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy.

Larsen CP, Walker PD.

Transplantation. 2013 May 27;95(10):1259-62. doi: 10.1097/TP.0b013e31828a947b.

PMID:
23514961
16.

Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.

Aguilera I, Alvarez-Marquez A, Gentil MA, Fernandez-Alonso J, Fijo J, Saez C, Wichmann I, Nuñez-Roldan A.

Nephrol Dial Transplant. 2008 Jul;23(7):2393-8. doi: 10.1093/ndt/gfm955. Epub 2008 Feb 28.

17.

The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction.

Ranjan P, Nada R, Jha V, Sakhuja V, Joshi K.

Nephrol Dial Transplant. 2008 May;23(5):1735-41. Epub 2007 Dec 8.

18.

Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.

Mauiyyedi S, Pelle PD, Saidman S, Collins AB, Pascual M, Tolkoff-Rubin NE, Williams WW, Cosimi AA, Schneeberger EE, Colvin RB.

J Am Soc Nephrol. 2001 Mar;12(3):574-82.

19.

Post-Transplant Membranous Nephropathy Associated with Chronic Active Antibody-Mediated Rejection and Hepatitis C Infection after Deceased Donor Renal Transplantation.

Doke T, Sato W, Takahashi K, Hayashi H, Koide S, Sasaki H, Kusaka M, Shiroki R, Hoshinaga K, Takeda A, Yuzawa Y, Hasegawa M.

Intern Med. 2016;55(4):375-80. doi: 10.2169/internalmedicine.55.5468. Epub 2016 Feb 15.

20.

[A case of membranous glomerulonephritis in renal allograft].

Kanno T, Ito M, Kawase N, Taki Y, Yoshida H, Okuno H, Ogawa O.

Hinyokika Kiyo. 2002 Jun;48(6):379-82. Japanese.

PMID:
12166242
Items per page

Supplemental Content

Write to the Help Desk